PedAM
Pediatric Disease Annotations & Medicines
| Disease | liver disease |
| Symptom | |cirrhosis |
| Sentences | 175 |
| PubMedID- 23936497 | Successful antiviral treatment in patients with advanced cirrhosis may halt progression of liver disease or prevent hcv re-infection of the liver graft in those awaiting liver transplantation . |
| PubMedID- 22359269 | The present study aimed to investigate the biological actions of tricin on hepatic stellate cells (hscs) in vitro, exploring its potential as a treatment of liver fibrosis, since hsc proliferation is closely related to the progression of hepatic fibrogenesis in chronic liver diseases leading to irreversible liver cirrhosis and hepatocellular carcinoma. |
| PubMedID- 22500261 | (3) chronic liver disease: patients diagnosed with liver cirrhosis by physicians with or without radiological confirmation, and patients diagnosed with chronic viral hepatitis on the basis of laboratory tests for the hepatitis a, b, and c viruses were classified into two groups; those with severe liver disease (such as liver cirrhosis with child-pugh class b, c) and those with mild liver disease (such as chronic viral hepatitis carrier, liver cirrhosis with child-pugh class a). |
| PubMedID- 24815066 | In some ccm cases the cardiac dysfunction in cirrhosis is not associated with the liver disease severity . |
| PubMedID- 22829332 | On the basis of the above-mentioned hypothesis that occult hbv might be unable to produce severe hepatic injury by itself, it appears difficult to provide an explanation to the considerable evidence indicating that obi is associated with the progression of liver fibrosis and cirrhosis development also in patients with cryptogenic liver disease . |
| PubMedID- 22420979 | Although cirrhosis and other causes of chronic liver disease have been implicated, their contribution as risk factors for cholangiocarcinoma is unclear and our aims were to analyze these emerging potential risk factors by systematic examination of case-control series from geographically diverse regions. |
| PubMedID- 26441244 | Non-alcoholic steatohepatitis (nash), as an extreme form of nafld, is associated with progressive liver disease and can lead to cirrhosis and ⁄ or hepatocellular carcinoma . |
| PubMedID- 25887140 | The estimated recruitment period is 24 months, and recruitment started in february 2014.table 1inclusion and exclusion criteriaainclusion criteriaexclusion criteriaage ≥18 years.age <18 years.written informed consent to participate in the clinical trial and written informed consent for genetic testing.absent written informed consent to participate in the clinical trial or for genetic testing.patients have to be able to understand and follow instructions and to be willing to attend all study visits (compliance).patients unable to understand the meaning of the clinical trial and the consequences of study participation.presence or history of ascites in case of advanced liver disease compatible with cirrhosis (liver biopsy not required).patients unable to understand or follow instructions or not willing to attend all study visits.diagnostic paracentesis to exclude sbp within 10 days before the baseline visit. |
| PubMedID- 25629773 | Hbv-aclf is a severe situation occurred under existing chronic liver disease with or without cirrhosis, which represents a complex situation which is different from cirrhosis . |
| PubMedID- 21970718 | After a sub-clinical phase, greater than 80% of patients progress to persistent hcv infection, the leading cause of chronic liver disease associated with cirrhosis and hepatocellular carcinoma . |
| PubMedID- 24376343 | The beneficial effects of a virologic response to entecavir in preventing progression of liver disease in patients with and without cirrhosis have also been observed in a study from taiwan.45 further, a virologic response to entecavir reduced the risk of clinical events and hepatocellular carcinoma in nucleos(t)ide-experienced patients with prior lamivudine-resistant or adefovir-resistant mutants, but not in nucleos(t)ide-naïve patients or nucleos(t)ide-experienced patients who had never developed lamivudine-resistant or adefovir-resistant mutants. |
| PubMedID- 23831905 | Autoimmune hepatitis (aih) is a chronic inflammatory liver disease leading to cirrhosis and its complications if left untreated. |
| PubMedID- 23546360 | In patients whom the liver is the most impaired organ, the liver disease can present with recurrent hepatitis, cirrhosis, or liver failure. |
| PubMedID- 22809449 | First, since the progression from fibrosis to cirrhosis, the end-point of chronic liver diseases, is characterized by a chronic and persistent inflammatory reaction , we suggest that such chronic inflammation, in addition to stimulating the local release of angiogenic factors by hepatic stellate cells and sinusoidal endothelial cells , may at the same time suppress the mobilization of epcs from bone marrow into the circulation. |
| PubMedID- 22745742 | Hepatitis c virus (hcv) is a major cause for chronic liver disease leading to liver cirrhosis and hepatocellular carcinoma (hcc) 1. |
| PubMedID- 22039521 | In most cases, hcv infection progresses to chronic liver disease, which can lead to liver cirrhosis and hepatocarcinoma 1. |
| PubMedID- 21910861 | The above three patients had atypical forms of chronic liver disease that lead to decompensated advanced cirrhosis in two of them. |
| PubMedID- 25276280 | Infection by the hcv can cause acute and chronic liver diseases and may lead to cirrhosis, hepatocellular carcinoma or liver failure. |
| PubMedID- 24475094 | Fibrosis is a consequence of chronic liver disease and may lead to cirrhosis and liver failure. |
| PubMedID- 21713221 | cirrhosis is a consequence of chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue and regenerative nodules leading to loss of liver function. |
| PubMedID- 20600032 | Background & aims: autoimmune hepatitis (aih) is a chronic liver disease associated with cirrhosis and liver failure. |
| PubMedID- 20556834 | The patients were affected by chronic liver diseases with cirrhosis which was proven histologically (n = 58); by chronic active hepatitis c (n = 4), chronic active hepatitis b (n = 2), and chronic persistent hepatitis c (n = 6). |
| PubMedID- 24367229 | The majority of patients (72%) had decompensated liver cirrhosis which was due to alcoholic liver disease except for one case with hepatitis virus c infection and α1-antitrypsin deficiency. |
| PubMedID- 25588648 | According to the world health organization (who), about 3 % of the world’s population has been infected with this virus and nearly 80 % of the infected individuals develop chronic liver disease, leading to liver cirrhosis and, in some cases, to hepatocellular carcinoma (who 2014). |
| PubMedID- 26077449 | Iron-overload-mediated liver disease leads to end-stage cirrhosis and/or hepatocellular carcinoma. |